These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28411071)

  • 21. [Prognostic value of venous tumor thrombus in renal cell carcinoma].
    García-Fadrique G; Budía-Alba A; Ruiz-Cerdá JL; Morales-Solchaga G; Pontones JL; Jiménez-Cruz JF
    Actas Urol Esp; 2012 Jan; 36(1):29-34. PubMed ID: 21802784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
    Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
    Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW
    Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
    Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
    An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
    Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus.
    Haddad AQ; Leibovich BC; Abel EJ; Luo JH; Krabbe LM; Thompson RH; Heckman JE; Merrill MM; Gayed BA; Sagalowsky AI; Boorjian SA; Wood CG; Margulis V
    Urol Oncol; 2015 Sep; 33(9):388.e1-9. PubMed ID: 26004163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension.
    Martínez-Salamanca JI; Huang WC; Millán I; Bertini R; Bianco FJ; Carballido JA; Ciancio G; Hernández C; Herranz F; Haferkamp A; Hohenfellner M; Hu B; Koppie T; Martínez-Ballesteros C; Montorsi F; Palou J; Pontes JE; Russo P; Terrone C; Villavicencio H; Volpe A; Libertino JA;
    Eur Urol; 2011 Jan; 59(1):120-7. PubMed ID: 20980095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma.
    Shao Y; Xiong S; Sun G; Dou W; Hu X; Yang W; Lia T; Deng S; Wei Q; Zeng H; Li X
    Cancer Med; 2020 Feb; 9(3):959-970. PubMed ID: 31840431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of renal cell carcinoma with tumor thrombus in renal vein and the inferior vena cava.
    Qi J; Gu Z; Chen F; Shen H; Chen J; Zhang L; Wang W
    Ann Vasc Surg; 2010 Nov; 24(8):1089-93. PubMed ID: 20471214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
    Sorbellini M; Kattan MW; Snyder ME; Reuter V; Motzer R; Goetzl M; McKiernan J; Russo P
    J Urol; 2005 Jan; 173(1):48-51. PubMed ID: 15592023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
    Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
    Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
    Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
    J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein.
    Kolla SB; Ercole C; Spiess PE; Pow-Sang JM; Sexton WJ
    BJU Int; 2010 Nov; 106(10):1494-8. PubMed ID: 20230378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.
    Abel EJ; Margulis V; Bauman TM; Karam JA; Christensen WP; Krabbe LM; Haddad A; Golla V; Wood CG
    BJU Int; 2016 Jun; 117(6B):E87-94. PubMed ID: 26305276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patients.
    Fu Q; Chang Y; Zhou L; An H; Zhu Y; Xu L; Zhang W; Xu J
    Oncotarget; 2016 Feb; 7(7):8413-21. PubMed ID: 26716905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a CT-assessed adiposity nomogram for predicting outcome in localized ccRCC.
    Li X; Zhang S; Huang X; Lin D; Zhou J
    Abdom Radiol (NY); 2024 Oct; 49(10):3485-3495. PubMed ID: 38842727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.
    Rodriguez Faba O; Linares E; Tilki D; Capitanio U; Evans CP; Montorsi F; Martínez-Salamanca JI; Libertino J; Gontero P; Palou J
    Eur Urol Focus; 2018 Apr; 4(3):435-441. PubMed ID: 28753848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.